In a rare Spanish takeover of a US company, family-controlled pharmaceutical group Grifols bought plasma specialist Talecris for $3.4bn in August.
Latin American drugs
In a rare Spanish takeover of a US company, family-controlled pharmaceutical group Grifols bought plasma specialist Talecris for $3.4bn in August.